DTYMK
Basic information
Region (hg38): 2:241675747-241686944
Links
Phenotypes
GenCC
Source:
- mitochondrial DNA depletion syndrome (Limited), mode of inheritance: AR
- neurodegeneration, childhood-onset, with progressive microcephaly (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodegeneration, childhood-onset, with progressive microcephaly | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Genitourinary; Neurologic | 31271740; 34918187 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (42 variants)
- Neurodegeneration,_childhood-onset,_with_progressive_microcephaly (6 variants)
- not_provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the DTYMK gene is commonly pathogenic or not. These statistics are base on transcript: NM_000012145.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 38 | 46 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 4 | 0 | 38 | 6 | 1 |
Highest pathogenic variant AF is 0.000013009814
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| DTYMK | protein_coding | protein_coding | ENST00000305784 | 5 | 11250 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.0000615 | 0.488 | 125709 | 0 | 39 | 125748 | 0.000155 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.251 | 122 | 130 | 0.938 | 0.00000856 | 1362 |
| Missense in Polyphen | 32 | 44.096 | 0.72569 | 480 | ||
| Synonymous | -0.309 | 62 | 59.0 | 1.05 | 0.00000421 | 427 |
| Loss of Function | 0.451 | 7 | 8.41 | 0.832 | 3.56e-7 | 103 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000239 | 0.000239 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000217 | 0.000217 |
| Finnish | 0.0000939 | 0.0000924 |
| European (Non-Finnish) | 0.000220 | 0.000220 |
| Middle Eastern | 0.000217 | 0.000217 |
| South Asian | 0.0000327 | 0.0000327 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the conversion of dTMP to dTDP.;
- Pathway
- Pyrimidine metabolism - Homo sapiens (human);Zidovudine Pathway, Pharmacokinetics/Pharmacodynamics;Pyrimidine metabolism;pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;Metabolism of nucleotides;Interconversion of nucleotide di- and triphosphates;Metabolism;superpathway of pyrimidine deoxyribonucleoside salvage;Pyrimidine nucleotides nucleosides metabolism;pyrimidine deoxyribonucleotide phosphorylation;superpathway of pyrimidine deoxyribonucleotides <i>de novo</i> biosynthesis;pyrimidine deoxyribonucleotides biosynthesis from CTP
(Consensus)
Recessive Scores
- pRec
- 0.272
Intolerance Scores
- loftool
- 0.368
- rvis_EVS
- -0.54
- rvis_percentile_EVS
- 20.26
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.376
- ghis
- 0.701
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.966
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Dtymk
- Phenotype
Gene ontology
- Biological process
- nucleoside diphosphate phosphorylation;dUDP biosynthetic process;dTDP biosynthetic process;dTTP biosynthetic process;cell population proliferation;nucleobase-containing small molecule interconversion;response to estrogen;myoblast differentiation;response to cadmium ion;nucleoside monophosphate phosphorylation;cellular response to growth factor stimulus
- Cellular component
- nucleus;cytoplasm;mitochondrion;mitochondrial intermembrane space;mitochondrial matrix;cytosol
- Molecular function
- nucleoside diphosphate kinase activity;thymidylate kinase activity;ATP binding;uridylate kinase activity;nucleoside monophosphate kinase activity